131
Participants
Start Date
February 28, 2010
Primary Completion Date
September 30, 2010
Study Completion Date
September 30, 2010
Pneumococcal Vaccine Formulation 1
0.5 mL, intramuscular (1 middle dose)
Pneumococcal Vaccine Formulation 2
0.5 mL, intramuscular (2 low doses)
Pneumococcal Vaccine Formulation 3
0.5 mL, intramuscular (2 middle doses)
Pneumococcal Vaccine Formulation 4
0.5 mL, intramuscular (2 middle doses)
Pneumococcal Vaccine Formulation 5
0.5 mL, intramuscular (2 high doses)
Placebo
0.5 mL, intramuscular
Allschwil
Lead Sponsor
Sanofi
INDUSTRY